SynthesisJournal of neuro-oncology2026

Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors?

Yaxel Levin-Carrion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.